抗肿瘤药物-话题@MedSci

#抗肿瘤药物#

6篇内容 | 2632人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2240156, encodeId=4add2240156f0, content=<a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a> <a href='/topic/show?id=74554084960' target=_blank style='color:#2F92EE;'>#国家医保目录#</a>, objectTitle=最新发布，2024医保抗肿瘤药物4表总结，多种创新疗法首进医保, objectType=article, longId=853319, objectId=9117853319e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719541210140_92910.jpg, objectUrl=/article/show_article.do?id=9117853319e2, replyNumber=0, likeNumber=32, createdTime=2024-11-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9117853319e2, moduleTitle=最新发布，2024医保抗肿瘤药物4表总结，多种创新疗法首进医保, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9117853319e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2217562, encodeId=d9cc221e56250, content=<a href='/topic/show?id=eacee7056bb' target=_blank style='color:#2F92EE;'>#紫杉类#</a> <a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a>, objectTitle=干货：紫杉类抗肿瘤药物在肿瘤科的应用全解析，建议收藏！, objectType=article, longId=836648, objectId=01fa836648e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722229778897_8538692.jpg, objectUrl=/article/show_article.do?id=01fa836648e0, replyNumber=0, likeNumber=70, createdTime=2024-07-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=01fa836648e0, moduleTitle=干货：紫杉类抗肿瘤药物在肿瘤科的应用全解析，建议收藏！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01fa836648e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2163254, encodeId=70e021632541d, content=<a href='/topic/show?id=9d3d812280b' target=_blank style='color:#2F92EE;'>#肝损伤#</a>的<a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a>, objectTitle=常见引起肝损伤的抗肿瘤药物, objectType=scale, longId=4194, objectId=4194, topicUrl=null, isHasObj=0, objectCover=https://static.medsci.cn/public-image/ms-image/c4014af0-a4f3-11ec-a1b8-6123b3ff61ea_企业微信截图_16472234662720.png, objectUrl=https://m.medsci.cn//scale/show.do?id=06d4419426, replyNumber=0, likeNumber=102, createdTime=2023-10-17, rootId=0, userName=litao2022, userId=1ff65466529, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4194, moduleTitle=常见引起肝损伤的抗肿瘤药物, moduleType=scale, hrefUrl=https://m.medsci.cn/scale/show.do?id=06d4419426)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2116719, encodeId=9d4b2116e19ad, content=<a href='/topic/show?id=2ad83e51258' target=_blank style='color:#2F92EE;'>#双特异性抗体#</a><a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a>临床研发技术<a href='/topic/show?id=222756406b7' target=_blank style='color:#2F92EE;'>#指导原则#</a>, objectTitle=双特异性抗体抗肿瘤药物临床研发技术指导原则, objectType=guider, longId=20678, objectId=1635f1c00280398e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=1635f1c00280398e, replyNumber=0, likeNumber=141, createdTime=2023-02-27, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1635f1c00280398e, moduleTitle=双特异性抗体抗肿瘤药物临床研发技术指导原则, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=1635f1c00280398e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2108378, encodeId=76af21083e819, content=新型<a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a><a href='/topic/show?id=cfdc22e893f' target=_blank style='color:#2F92EE;'>#临床应用#</a><a href='/topic/show?id=222756406b7' target=_blank style='color:#2F92EE;'>#指导原则#</a>, objectTitle=新型抗肿瘤药物临床应用指导原则(2022年版), objectType=guider, longId=21629, objectId=dd9041c002899078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=dd9041c002899078, replyNumber=0, likeNumber=144, createdTime=2023-01-01, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=dd9041c002899078, moduleTitle=新型抗肿瘤药物临床应用指导原则(2022年版), moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=dd9041c002899078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1242641, encodeId=97451242641cd, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#贝伐珠单抗#</a><a href='/topic/show?id=aeef922031b' target=_blank style='color:#2F92EE;'>#贝伐单抗#</a>是万能搭配，与各种<a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a>都可以联用, objectTitle=关于贝伐珠单抗，你想知道的全在这里, objectType=article, longId=726226, objectId=ce72e262261f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220505/1651750094044_5486984.png, objectUrl=/article/show_article.do?id=ce72e262261f, replyNumber=0, likeNumber=148, createdTime=2022-09-02, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce72e262261f, moduleTitle=关于贝伐珠单抗，你想知道的全在这里, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce72e262261f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1236504, encodeId=17381236504e8, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a><a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a><a href='/topic/show?id=4b88612e5e' target=_blank style='color:#2F92EE;'>#DNA甲基化#</a>, objectTitle=中药：一类潜在可靠的表观遗传药物, objectType=article, longId=734029, objectId=0416e3402996, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659318166540_5552845.jpg, objectUrl=/article/show_article.do?id=0416e3402996, replyNumber=0, likeNumber=188, createdTime=2022-08-04, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0416e3402996, moduleTitle=中药：一类潜在可靠的表观遗传药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0416e3402996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=996225, encodeId=c5539962251e, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准<a href='/topic/show?id=6b68556562e' target=_blank style='color:#2F92EE;'>#抗肿瘤药物#</a>汇总，这里总结详细！！, objectTitle=2021年上半年盘点：FDA批准抗肿瘤药物汇总, objectType=article, longId=213749, objectId=b40b213e49de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201229/1609214723272_5295902.jpeg, objectUrl=/article/show_article.do?id=b40b213e49de, replyNumber=0, likeNumber=234, createdTime=2021-07-04, rootId=0, userName=小小医者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40b213e49de, moduleTitle=2021年上半年盘点：FDA批准抗肿瘤药物汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40b213e49de)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗肿瘤药物

2020-05-29

梅斯管理员

#抗肿瘤药物# #国家医保目录#

最新发布，2024医保抗肿瘤药物4表总结，多种创新疗法首进医保

2024-11-30发表于陕西省

梅斯管理员

#紫杉类# #抗肿瘤药物#

干货：紫杉类抗肿瘤药物在肿瘤科的应用全解析，建议收藏！

2024-07-30发表于上海

#肝损伤#的#抗肿瘤药物#

常见引起肝损伤的抗肿瘤药物

2023-10-17发表于上海

showtest

#双特异性抗体##抗肿瘤药物#临床研发技术#指导原则#

双特异性抗体抗肿瘤药物临床研发技术指导原则

2023-02-27发表于上海

侠胆医心

新型#抗肿瘤药物##临床应用##指导原则#

新型抗肿瘤药物临床应用指导原则(2022年版)

2023-01-01发表于上海

循证小兵

#贝伐珠单抗##贝伐单抗#是万能搭配，与各种#抗肿瘤药物#都可以联用

关于贝伐珠单抗，你想知道的全在这里

2022-09-02

病毒猎手

#中药##抗肿瘤药物##DNA甲基化#

中药：一类潜在可靠的表观遗传药物

2022-08-04

小小医者

#FDA#批准#抗肿瘤药物#汇总，这里总结详细！！

2021年上半年盘点：FDA批准抗肿瘤药物汇总

2021-07-04